Depletion of CD8+ CART cells leads to superior anti-tumor efficacy of pure CD4+ CART cells against acute leukemias
Qian Chen, David Sedloev, Hao Yao, Lianghao Mao, Dominic Depke, Lei Wang, Marina Scheller, Bailin He, Yi Liu, Julia M. Unglaub, Anita Schmitt, Ashok Kumar Jayavelu, Carsten Müller-Tidow, Michael Schmitt, Tim Sauer · 2026
Read Depletion of CD8+ CART cells leads to superior anti-tumor efficacy of pure CD4+ CART cells against acute leukemias by Qian Chen, David Sedloev, Hao Yao, Lianghao Mao, Dominic Depke, Lei Wang, Marina Scheller, Bailin He, Yi Liu, Julia M. Unglaub, Anita Schmitt, Ashok Kumar Jayavelu, Carsten Müller-Tidow, Michael Schmitt, Tim Sauer (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13464297.txt.
Description
Qian Chen and colleagues found in 2026 that CAR-T products made purely of CD4 cells fight acute leukaemias better than mixes containing CD8 cells. Treatment failure still blocks lasting remissions in blood cancers, so the best cell mix for CAR-T products matters greatly. Lab work showed pure CD4 products killed more and multiplied faster than CD8-containing mixes.
Gene and protein studies showed pure CD4 cells held a proliferative, killer-like state, while CD8 neighbours stripped them of cell-cycle machinery and pushed them toward death. The culprit was competition for shared tumour antigen. Removing CD8 cells may therefore sharpen CAR-T therapy for leukaemia, a design change that trials can test directly.
Catalog record
| CREATOR | Qian Chen, David Sedloev, Hao Yao, Lianghao Mao, Dominic Depke, Lei Wang, Marina Scheller, Bailin He, Yi Liu, Julia M. Unglaub, Anita Schmitt, Ashok Kumar Jayavelu, Carsten Müller-Tidow, Michael Schmitt, Tim Sauer |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 96 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |